Emerging Infectious Diseases (Apr 2021)
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva
- Isabel M. Ott,
- Madison S. Strine,
- Anne E. Watkins,
- Maikel Boot,
- Chaney C. Kalinich,
- Christina A. Harden,
- Chantal B.F. Vogels,
- Arnau Casanovas-Massana,
- Adam J. Moore,
- M. Catherine Muenker,
- Maura Nakahata,
- Maria Tokuyama,
- Allison Nelson,
- John Fournier,
- Santos Bermejo,
- Melissa Campbell,
- Rupak Datta,
- Charles S. Dela Cruz,
- Shelli F. Farhadian,
- Albert I. Ko,
- Akiko Iwasaki,
- Nathan D. Grubaugh,
- Craig B. Wilen,
- Anne L. Wyllie
Affiliations
- Isabel M. Ott
- Madison S. Strine
- Anne E. Watkins
- Maikel Boot
- Chaney C. Kalinich
- Christina A. Harden
- Chantal B.F. Vogels
- Arnau Casanovas-Massana
- Adam J. Moore
- M. Catherine Muenker
- Maura Nakahata
- Maria Tokuyama
- Allison Nelson
- John Fournier
- Santos Bermejo
- Melissa Campbell
- Rupak Datta
- Charles S. Dela Cruz
- Shelli F. Farhadian
- Albert I. Ko
- Akiko Iwasaki
- Nathan D. Grubaugh
- Craig B. Wilen
- Anne L. Wyllie
- DOI
- https://doi.org/10.3201/eid2704.204199
- Journal volume & issue
-
Vol. 27,
no. 4
pp. 1146 – 1150
Abstract
The expense of saliva collection devices designed to stabilize severe acute respiratory syndrome coronavirus 2 RNA is prohibitive to mass testing. However, virus RNA in nonsupplemented saliva is stable for extended periods and at elevated temperatures. Simple plastic tubes for saliva collection will make large-scale testing and continued surveillance easier.
Keywords
- 2019 novel coronavirus disease
- coronavirus disease
- COVID-19
- severe acute respiratory syndrome coronavirus 2
- SARS-CoV-2
- viruses
